Table A7.
Changes in Infant Characteristic | Months after Birth | |||||
---|---|---|---|---|---|---|
5 and 2 | 9 and 2 | 12 and 2 | 9 and 5 | 12 and 5 | 12 and 9 | |
Calculated daily intake of adiponectin (ng) between 2 and 5 months e | ||||||
ΔLength (cm) | −0.0001 (0.0001) a 0.074 b,c |
0.0002 (0.0001) 0.079 |
0.00004 (0.0001) 0.76 |
0.0002 (0.0001)
0.010 |
0.0001 (0.0001) 0.47 |
−0.0001 (0.0001) 0.39 |
ΔFat-free mass US 4SF d (kg) | −0.00002 (0.00002) 0.43 |
0.0001 (0.00002)
0.036 |
0.0001 (0.00003)
0.043 |
−0.0001 (0.00002)
0.011 |
0.0001 (0.00003)
0.018 |
0.00001 (0.00002) 0.41 |
ΔFat-free mass index US 2SF (kg/m2) | 0.00004 (0.0001) 0.42 |
0.0001 (0.00004) 0.28 |
0.0001 (0.00004)
0.026 |
−0.00002 (0.0001) 0.77 |
0.00004 (0.0001) 0.54 |
0.00001 (0.00004) 0.17 |
ΔFat-free mass index US 4SF (kg/m2) | 0.00002 (0.0001) 0.67 |
0.0001 (0.00001) 0.092 |
0.0002 (0.00004)
0.009 |
0.0001 (0.00001) 0.27 |
0.0001 (0.0001) 0.057 |
0.00001 (0.0001) 0.22 |
ΔFat-free mass index BIS (kg/m2) | 0.0001 (0.00003) 0.098 |
0.0001 (0.0001) 0.23 |
0.0001 (0.00004)
0.029 |
0.00002 (0.0001) 0.67 |
0.00004 (0.0001) 0.54 |
0.00004 (0.0001) 0.44 |
ΔFat mass US 4SF (kg) | 0.00001 (0.00001) 0.50 |
−0.00003 (0.00002) 0.22 |
−0.00004 (0.00003) 0.22 |
−0.00004 (0.00003) 0.17 |
−0.0001 (0.00002)
0.049 |
−0.00001 (0.00001) 0.68 |
ΔFat mass US 4SF (%) | 0.0001 (0.0002) 0.62 |
−0.001 (0.0002)
0.044 |
−0.001 (0.0003) 0.099 |
−0.001 (0.0003)
0.044 |
−0.001 (0.0002)
0.007 |
−0.0001 (0.0002)
0.047 |
ΔFat mass index US 4SF (kg/m2) | 0.00003 (0.00003) 0.36 |
−0.0001 (0.0001) 0.10 |
−0.0001 (0.0001) 0.25 |
−0.0001 (0.0001) 0.059 |
−0.0001 (0.0001)
0.044 |
0.000 (0.00003) 0.99 |
Calculated daily intake of adiponectin (ng) at 9 months e | ||||||
ΔHead circumference (cm) | n/a f | 0.0004 (0.0004) 0.42 |
−0.0002 (0.0004) 0.64 |
0.0001 (0.0001) 0.32 |
−0.0002 (0.0001) 0.066 |
−0.0003 (0.0001)
0.017 |
Calculated daily intake of adiponectin (ng) at 12 months e | ||||||
ΔFat-free mass index US 4SF (kg/m2) | n/a f | n/a f | −0.001 (0.001) 0.39 |
n/a |
−0.001 (0.0002)
0.020 |
−0.0004 (0.0003) 0.23 |
ΔFat mass index US 2SF (kg/m2) | n/a | n/a |
0.001 (0.0001)
0.005 |
n/a f | 0.00002 (0.0003) 0.95 |
0.00002 (0.0002) 0.90 |
ΔFat mass US 2SF (kg) | n/a | n/a |
0.001 (0.0001)
0.012 |
n/a | −0.00003 (0.0001) 0.82 |
0.0001 (0.0001) 0.26 |
ΔFat mass BIS (kg) | n/a | n/a |
0.001 (0.0001)
0.018 |
n/a | −0.0002 (0.0001) 0.17 |
−0.0001 (0.0002) 0.59 |
ΔFat mass US 2SF (%) | n/a | n/a |
0.009 (0.002)
0.013 |
n/a | 0.001 (0.001) 0.63 |
0.001 (0.001) 0.46 |
ΔFat mass BIS (%) | n/a | n/a |
0.007 (0.001)
0.011 |
n/a | −0.002 (0.001) 0.26 |
−0.001 (0.002) 0.63 |
a Parameter estimates ± SE and b p-values for associations between calculated daily intakes (CDI) of adiponectin at given time points and the changes (Δ) in measured variables between different months after birth. c Results are presented only for variables with at least one significant raw p-value (p < 0.05, indicated by the bold text); after the false discovery rate adjustment, the predictor p-values were considered to be significant at <0.007 for CDI of whole milk adiponectin between 2 and 5 months, at <0.017 for CDI at 9 months and at <0.005 for CDI at 12 months (none are significant). d BIS—bioimpedance spectroscopy; BMI—body mass index; US 2SF—ultrasound 2-skinfolds; US 4SF—ultrasound 4-skinfolds. e CDI were measured between 2 and 5 months (n = 17) and within 2 weeks of 9 (n = 8) and 12 months (n = 8). f Results are not presented for impractical time combinations, n/a—not applicable.